
Professor of Clinical Medicine
M_MED-ZSFG-AIDS
+1 415 502-5753
I specialize in HIV/AIDS and have clinical responsibilities including outpatient services at the San Francisco General Hospital HIV clinic as well as inpatient services on the HIV/AIDS, general medicine, and infectious diseases consult services. I direct the HIV Clinical Trials Group at SFGH, which conducts investigator-initiated and industry HIV trials. I am site investigator for the Adult AIDS Clinical Trials Group (ACTG), and my research interests include HIV and TB coinfection, development of novel TB diagnostics, and HIV and viral hepatitis coinfection.
Publications
Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis.
The Journal of antimicrobial chemotherapy
Remdesivir for the Treatment of Covid-19 - Preliminary Report.
M_MED-CORE-PULM
Ledipasvir/Sofosbuvir for 8 Weeks to Treat Acute Hepatitis C Virus Infections in Men With Human Immunodeficiency Virus Infections: Sofosbuvir-Containing Regimens Without Interferon for Treatment of Acute HCV in HIV-1 Infected Individuals.
The American journal of tropical medicine and hygiene
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
The American journal of tropical medicine and hygiene
A survey of tuberculosis infection control practices at the NIH/NIAID/DAIDS-supported clinical trial sites in low and middle income countries.
H-Center for TB
12 Weeks of Daclatasvir in Combination With Sofosbuvir for HIV-HCV Coinfection (ALLY-2 Study): Efficacy and Safety by HIV Combination Antiretroviral Regimens.
The American journal of tropical medicine and hygiene
Evaluation of Xpert MTB/RIF Versus AFB Smear and Culture to Identify Pulmonary Tuberculosis in Patients With Suspected Tuberculosis From Low and Higher Prevalence Settings.
The American journal of tropical medicine and hygiene
Combined effect of CYP2B6 and NAT2 genotype on plasma efavirenz exposure during rifampin-based antituberculosis therapy in the STRIDE study.
The American journal of tropical medicine and hygiene
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.
The American journal of tropical medicine and hygiene
Significant variation in presentation of pulmonary tuberculosis across a high resolution of CD4 strata.
JCI insight
Tuberculosis as part of the natural history of HIV infection in developing countries.
The American journal of tropical medicine and hygiene